The document discusses the case of a 20-year-old patient with Prader-Willi syndrome who was referred for sleep apnea. A polysomnography showed central apneas, desaturations, and low respiratory flow. The patient was diagnosed with obstructive sleep apnea predominantly with hypopneas and had an apnea-hypopnea index of 54.8/hour and desaturation index of 27/hour. Treatment with CPAP titration during sleep was recommended.
Presentation of Dr. Dean Hess at 10th Pulmonary Medicine Update Course, Cairo, Egypt. Pulmonary Medicine Update Course is organized by Scribe : www.scribeofegypt.com
Pain Physicians should consider nerve blocks when systemic analgesics are failing. (Adjuvant therapy)
Careful selection of patients
Benefits should outweigh the risks
Thorough knowledge of the limitations and side effects
Need for randomized controlled clinical trials.
Neuropathic pain poses a challenge to effective rehabilitation. Best practice, considerations & the use of Action Potential Simulation therapy to effectively treat neuropathic pain, sharing our results from a 2 year research project in people with MS.
Neuropathic pain poses a challenge to effective rehabilitation. Best practice, considerations & the use of Action Potential Simulation therapy to effectively treat neuropathic pain, sharing our results from a 2 year research project in people with MS.
Presentation of Dr. Dean Hess at 10th Pulmonary Medicine Update Course, Cairo, Egypt. Pulmonary Medicine Update Course is organized by Scribe : www.scribeofegypt.com
Pain Physicians should consider nerve blocks when systemic analgesics are failing. (Adjuvant therapy)
Careful selection of patients
Benefits should outweigh the risks
Thorough knowledge of the limitations and side effects
Need for randomized controlled clinical trials.
Neuropathic pain poses a challenge to effective rehabilitation. Best practice, considerations & the use of Action Potential Simulation therapy to effectively treat neuropathic pain, sharing our results from a 2 year research project in people with MS.
Neuropathic pain poses a challenge to effective rehabilitation. Best practice, considerations & the use of Action Potential Simulation therapy to effectively treat neuropathic pain, sharing our results from a 2 year research project in people with MS.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
TEST BANK For Timby's Introductory Medical-Surgical Nursing, 13th American Ed...kevinkariuki227
TEST BANK For Timby's Introductory Medical-Surgical Nursing, 13th American Edition by Donnelly-Moreno, Verified Chapters 1 - 72, Complete Newest Version.pdf
TEST BANK For Timby's Introductory Medical-Surgical Nursing, 13th American Edition by Donnelly-Moreno, Verified Chapters 1 - 72, Complete Newest Version.pdf
Why invest into infodemic management in health emergenciesTina Purnat
A lecture discussing the challenge of health misinformation and information ecosystem in public health, how this impacts demand promotion in health, and how this then relates to responding to misinformation and infodemics in health emergencies. Appended with lots of tools, guidance and resources for people who want to do more reading.
EATING DISORDERS (Psychiatry-7)by dr Shivam sharma.pptxShivam Sharma
For any queries ,contact shvmshrm@outlook.com
---
## Introduction to Eating Disorders
Welcome to this comprehensive presentation on Eating Disorders, a critical and often misunderstood area of mental health. This presentation is designed to provide in-depth knowledge and insights into the various aspects of eating disorders, making it valuable for both postgraduate medical aspirants preparing for the INI-CET and the general public seeking to understand these complex conditions.
### Objectives:
1. **Understanding Eating Disorders**: Gain a clear understanding of what eating disorders are, their types, and their distinguishing characteristics.
2. **Etiology and Risk Factors**: Explore the underlying causes and risk factors that contribute to the development of eating disorders.
3. **Clinical Features and Diagnosis**: Learn about the clinical features, diagnostic criteria, and the importance of early detection.
4. **Management and Treatment**: Review the current approaches to managing and treating eating disorders, including medical, psychological, and nutritional interventions.
5. **Prevention and Awareness**: Discuss strategies for prevention, early intervention, and increasing awareness about eating disorders.
This presentation aims to bridge the gap between academic knowledge and practical understanding, providing you with the tools to recognize, diagnose, and effectively manage eating disorders. Whether you are preparing for a medical exam or seeking to educate yourself or others about these serious conditions, this presentation will equip you with essential information and practical insights.
Let's begin our journey into understanding eating disorders and the significant impact they have on individuals and society.
---
For any queries ,contact shvmshrm@outlook.com
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
7. Polisomnografie Durations Patient name : SERESAN Acq : 707 First name : MARIA Type : Adult Sex : F Started : 11/4/2008 at 10:18:13 PM Birth date : 9/20/1988 Stopped : 11/5/2008 at 7:01:13 AM Patient age : 20 years Duration : 8:43:00 (523.0 min) Recording duration : 523.0 min Recording start -> end TIB : 523.0 min Light off -> Light on SPT : 488.5 min Sleep Onset -> Last Sleep Page TST : 469.0 min REM + NREM + MVT (during SPT) WK before sleep : 32.0 min WK from Light off to Sleep onset WK during sleep : 19.5 min SPT - TST WK after sleep : 0.0 min WK from Last sleep page to Light on TWK duration (tot) : 51.5 min All WK summed REM duration : 55.0 min REM (during TIB) NREM duration : 416.0 min S1 + S2 + S3 + S4 (during TIB) SWS duration : 78.5 min S3 + S4 (during TIB) Movement : 0.5 min MVT (during TIB)
8. Caracteristicile somnului Latencies From Light off (min) From Sleep onset (min) Sleep onset 34.5 - S1 32.0 12.5 S2 34.5 0.0 S3 144.5 110.0 S4 REM 253.5 219.0 Sleep efficiency 1 : 89.7% 100 x TST/TIB Sleep efficiency 2 : 96.0% 100 x TST/SPT Sleep efficiency 3 : 28.5% 100 x (N3+REM)/TST Inter-sleep WK : 4.0% WK in sleep / SPT
9. Evenimente respiratorii CA OA MA Sum Ap HYP Events Settings (sec) 10.0 10.0 10.0 - 10.0 - Number 4 47 1 52 376 428 Max (sec) 15.5 22.5 12.0 22.5 53.0 53.0 Mean (sec) 13.4 12.0 12.0 12.1 16.0 15.5 Tot duration (min) 0.9 9.4 0.2 10.5 100.0 110.5 TST (469.0 min) % of TST 0.2 2.0 0.0 2.2 21.3 23.6 Index [#/h TST] 0.5 6.0 0.1 6.7 48.1 54.8
12. REM #/h (REM) NREM #/h(NREM) TST #/h (sleep) RDI 31.6 57.8 54.8 Central apnea total duration : 1.68 minutes (0.3% of sleep) Total number of central apnea : 12 ( 1.5 CA/h (sleep)) Sigh rate : 8% Periodic breathing total duration : 1.57 minutes (0.3% of sleep)
15. Saturatia in O2 WK REM NREM TOTAL Fail duration (min) 0.2 0.0 0.0 0.2 Average (%) 98 97 96 96 Desat Index (#/hour) 8.7 29.7 27.2 Duration desat/hour 1.8 6.3 5.8 Desat max (%) 0 5 19 19 Desat max dur (sec) 0.0 20.0 45.0 45.0
16. Desaturari Longest continuous duration spent below 0%: 0.0 minute(s) Lowest SpO 2 (>= 2 seconds) [%]: 79 # Episodes (>= 5.0 minutes) SpO 2 < 88 %: 0 Longest duration SpO 2 < 88 % 0.0 minute(s) Mean of the resp. event SpO 2 min levels [%] : 93 Mean of the resp. event SpO 2 min levels with desat [%] : 92 Minimum of the resp. event SpO 2 min levels [%] 79
17. Total number of WK or MVT episodes : 3 Arousal index : 5.8/h(sleep) % of pages with arousal during sleep : 4.8 Number of arousals associated with leg movements : 0 Number of arousals NOT associated with leg movements : 45
25. CPAP 80% din pacienţi acceptă CPAP ca terapie de lungă durată la domiciliu W. T. McNicholas, M. R. Bonsignore, Eur Respir J , January 2007; 29:156-178
26.
27. CPAP: impact ul asupra activităţii din timpul zilei Engleman HM et al, Lancet 1994;343:572–575 Engleman HM et al, Thorax 1998;53:341–345 Redline S et al, AJRCCM 1998;57:858–865 Jenkinson C et al, Lancet 1999;353:2100–2105 Ballester E et al, AJRCCM 1999;159:495–501 Montserrat et al, AJRCCM, 2001, 164:608-13 nCPAP aduce îmbunătăţiri semnificative pe somnolenţă şi calitatea vieţii la pacienţii cu simptome de SAS moderată sau severă R Davies and J Stradling, AJRCCM, 2000, 161:1775-8
31. Mortalit atea crescută la pacienţii care nu primesc CPAP Doherty LS Chest. 2005;127:2076-2084 Long-term Effects of Nasal Continuous Positive Airway Pressure Therapy on Cardiovascular Outcomes in Sleep Apnea Syndrome* Chest. 2005;128:624-633. Mortality in Obstructive Sleep Apnea-Hypopnea Patients Treated With Positive Airway Pressure* Francisco Campos-Rodriguez, Marti, S, Sampol, G, Muñoz, X, et al Mortality in severe sleep apnoea/hypopnoea syndrome patients: impact of treatment. Eur Respir J 2002;20 ,1511-1518
32.
33.
34.
35. Circumferinţa abdominală medie 120,06 cm Obezitatea abdominală (plus ≥2 elemente) - element obligatoriu în noua definiţie a sindromului metabolic: peste 80 cm la femei şi peste 94 la bărbaţi la europeni Lancet 2007; 369:2059-2061